Dadachanji Group launches Kaisha Pharma for glass packaging

image credit- freepik

Mumbai-headquartered Dadachanji Group has launched Kaisha Pharma, a premier global platform engineered to serve the pharmaceutical and biotechnology sectors worldwide. As part of a substantial multi-million-euro commitment, the Group has already deployed an initial investment of €45 million to accelerate infrastructure, scale, and operational capabilities.

Kaisha Pharma enters the market with a complete tubular glass portfolio — ampoules, vials, prefilled syringes, and cartridges — together with advanced Ready-to-Use (RTU) platforms for vials, prefilled syringes, and cartridges. These solutions are designed to enable safer, faster, and more efficient fill-finish operations while meeting the increasingly stringent expectations of global pharmaceutical manufacturers.

The manufacturing complex will span over 300,000 square feet, with fully integrated state-of-the-art production lines, sophisticated high-end camera inspection systems, and fully equipped laboratories incorporating the latest analytical and testing equipment.